Follow the EDGC stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, EDGC has logged 49 public disclosures. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 에이아이티스토리. The full history is accessible without an account.
49
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
6 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
EDGC is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the field of medical diagnostics and treatments.
